characteristics.text: 2025-11-21
characteristics.characteristic: ENA first public
characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: Japanese Foundation for Cancer Research
characteristics.characteristic: INSDC center name
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS27360491
characteristics.characteristic: SRA accession
characteristics.text: E-MTAB-16203:Sample 4
characteristics.characteristic: Submitter Id
characteristics.text: ArrayExpress
characteristics.characteristic: broker name
characteristics.text: not collected
characteristics.characteristic: collection date
characteristics.text: human
characteristics.characteristic: common name
characteristics.text: Protocols: Organoids cultured with GSK126 treatment or vehicle control were used as input material, with 2 × 10^5 cells per reaction. CUT&Tag was performed using the CUT&Tag-IT Assay Kit (Active Motif, Cat. No. 53160) according to the manufacturer’s protocol.  CUT&Tag was performed using the CUT&Tag-IT Assay Kit (Active Motif, Cat. No. 53160) according to the manufacturer’s protocol.
characteristics.characteristic: description
characteristics.text: adult
characteristics.characteristic: developmental stage
characteristics.text: colorectal cancer
characteristics.characteristic: disease
characteristics.text: not collected
characteristics.characteristic: geographic location (country and/or sea)
characteristics.text: not applicable
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: patient-derived organoid
characteristics.characteristic: organism part
characteristics.text: Homo sapiens
characteristics.characteristic: scientific_name
characteristics.text: Sample 4
characteristics.characteristic: title